FDA Warns CVS, Others Against Selling Unapproved Eye Products | Old North State Wealth News
Connect with us


FDA warns CVS, others against selling unapproved eye products



(Reuters) -The U.S. Food and Drug Administration on Tuesday warned eight companies, including pharmacy giants CVS Health Corp (NYSE:) and Walgreens Boots Alliance (NASDAQ:), against manufacturing or marketing unapproved ophthalmic drug products.

The eye products addressed in its letters to these companies are illegally marketed to treat conditions like conjunctivitis, cataract and glaucoma, the FDA said. It said such drugs pose an increased risk to users as they can bypass some of the body’s natural defenses.

CVS and Walgreens did not immediately respond to Reuters requests for comment.

The U.S. health regulator has asked the companies to respond within 15 days of receipt of the letters and state how they will correct the violations.

The FDA warns that failure to correct the violations may result in legal action, including product seizure and court orders requiring companies to stop manufacturing and distributing an unapproved product.

Read the full article here


Copyright © 2022 ONSWM News. Content posted on the Old North State Wealth News page was developed and produced by a third party news aggregation service. Old North State Wealth Management is not affiliated with the news aggregation service. The information presented is believed to be current. It should not be viewed as personalized investment advice. All expressions of opinion reflect the judgment of the authors on the date the articles were published. The information presented is not an offer to buy or sell, or a solicitation of any offer to buy or sell, any of the securities discussed.